r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

DM

David Moatazedi

Insider · Director and Officer · EOLS

David Moatazedi files insider transactions with the SEC as a director and officer of Evolus (EOLS). We hold 4 disclosed purchases and sales filed since 15 March 2017, 2 of them in the last 90 days.

  • Files forEOLS
  • Disclosed buys and sells4 in all, 2 in the last 90 days
  • Last disclosure4 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 May 2018 — 2 September 2026Director and Officer · Evolus (EOLS)66 Form 4 lines · source: SEC Form 4
  • Filed 20 April 2023 — 26 August 2026Director · Biomerica (BMRA)6 Form 4 lines · source: SEC Form 4
  • Filed 13 March 2017 — 23 July 2019Director · Obalon Therapeutics (OBLN)6 Form 4 lines · source: SEC Form 4

Everything they disclosed

78 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.